معرفی
Mari Aksnes is a Postdoctoral Fellow at the Geriatric Department, Faculty of Medicine, University of Oslo, and affiliated with Oslo University Hospital’s dementia research group at Ullevål. Her work bridges neuroscience and geriatric medicine, focusing on the biological underpinnings of Alzheimer’s disease and dementia.
- PhD in Geriatrics and Neuroscience, University of Oslo (2018–2022)
- MSc in Neuroscience, Norwegian University of Science and Technology (2015–2017)
- BSc in Psychology, University of Durham (2012–2015)
Her research centers on neurodegeneration, particularly the role of biomarkers such as amyloidogenic nanoplaques and matrix metalloproteinases in Alzheimer’s disease. A key focus of her postdoctoral project, FEMDEM, is understanding why women are disproportionately affected by Alzheimer’s, investigating the interplay between sex hormones, genetics, and neurobiology. She employs cerebrospinal fluid analysis and clinical data to uncover sex-specific disease mechanisms.
Her recent publications reveal trends in sex-specific neuroinflammation, protease activity, and metabolite profiles in Alzheimer’s and delirium. She has contributed to understanding kynurenic acid as a neuroprotective agent and matrix metalloproteinases as markers of brain atrophy and cognitive decline.
Mari Aksnes has not received any explicitly mentioned scientific awards. She has not advised any named students in the provided text.
She has been involved in research teams at the University of Oslo and Oslo University Hospital, particularly within the dementia research group. Her work is highly collaborative, involving multi-institutional teams focused on biomarker discovery and sex differences in neurodegeneration.
